Detalhe da pesquisa
1.
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
Eur J Neurol
; 29(11): 3368-3379, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841212
2.
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
Clin Immunol
; 229: 108786, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147649